Clinical Trial Update: HVA vs IA/DA or VA in the Treatment of ND HR-AML [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing HVA regimens against IA/DA or VA regimens for newly diagnosed high-risk acute myeloid leukemia is currently recruiting at Nan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Newly Diagnosed Acute Myeloid Leukemia With High Risk | Phase 3 | Status: RECRUITING